tirzepatide reactions IM Tirzepatide (Zepbound, Mounjaro): Weight Loss,

[114] randomized subjects to semaglutide or placebo to observe the change of liver fat from baseline to week 48, and found that semaglutide significantly reduced hepatic steatosis, improved liver enzymes and metabolic parameters, and had a positive effect on the diagnosis and treatment of NAFLD compared with placebo

Phase 3 data confirms 15.6% average weight loss at 68 weeks - 50% more than semaglutide alone - with synergistic effects producing 20-25% loss in excellent responders

Leathwood PD, Chauffard F, Heck E, Munoz-Box R

C., & Hearne, E

GLP-1 RAs are known to have both direct and indirect renoprotective effects and are also associated with hepatic health benefits (Grade A

This medication will help patients reduce their high blood pressure and cholesterol medication dosages or get off them altogether